Zobrazeno 1 - 10
of 252
pro vyhledávání: '"Yoshio, Aizawa"'
Autor:
Takeshi Fukuda, MD, Yoshihiro Sakimoto, MD, Kenichi Narita, MD, Mitsuko Ariizumi, MD, PhD, Yoshio Aizawa, MD, PhD, Kunihiko Fukuda, MD, PhD
Publikováno v:
Radiology Case Reports, Vol 12, Iss 4, Pp 701-705 (2017)
Most gallbladder carcinomas are adenocarcinomas, of which mucinous carcinoma (MC) is a rare pathologic subtype. Signet ring cells are seldom found in MCs. We report an extremely rare case of gallbladder MC with signet ring cells. This is the first ra
Externí odkaz:
https://doaj.org/article/6193cddcbce146adbc4717e015ecd388
Autor:
Kaoru Ueda, Yoshio Aizawa, Chika Kinoshita, Tomohisa Nagano, Jinya Ishida, Chisato Saeki, Tsunekazu Oikawa, Toru Harada, Atsushi Hokari, Masayuki Saruta
Publikováno v:
Medicine. 101(29)
BACKGROUND Centrilobular zonal necrosis (CZN) is advocated as a histological hallmark present in a small number of patients with autoimmune hepatitis (CZN-AIH). Moreover, CZN has been detected in the absence of significant interface hepatitis, one of
Autor:
Chikara Ogawa, Katsuhiko Iwakiri, Hiroshi Abe, Takashi Kumada, Haruki Uojima, Shinya Fukunishi, Naoki Hotta, Tadashi Ikegami, Akito Nozaki, Takuya Genda, Kunihiko Tsuji, Makoto Nakamuta, Chisa Kondo, Noritomo Shimada, Yasuhito Tanaka, Hidenori Toyoda, Takehiro Akahane, Koichi Takaguchi, Tsunamasa Watanabe, Masanori Atsukawa, Yoshio Aizawa, Yoshihiko Tachi, Kojiro Michitaka, Toshihide Shima, Akihito Tsubota
Publikováno v:
Alimentary Pharmacology & Therapeutics. 49:1230-1241
BACKGROUND Patients with chronic hepatitis C are often complicated by chronic kidney disease (CKD). AIM To evaluate the efficacy, safety and pharmacokinetics of glecaprevir/pibrentasvir in patients with severe renal impairment. METHODS In a prospecti
Autor:
Hiroshi Abe, Akihito Tsubota, Noritomo Shimada, Masanori Atsukawa, Keizo Kato, Koichi Takaguchi, Toru Asano, Yoshimichi Chuganji, Choitsu Sakamoto, Hidenori Toyoda, Takashi Kumada, Tatsuya Ide, Michio Sata, Yoshio Aizawa
Publikováno v:
Gastroenterology Research and Practice, Vol 2014 (2014)
We evaluated the genetic variation in rs8099917, substitutions in core amino acid (aa) 70, and the number of aa substitutions in the interferon sensitivity-determining region (ISDR) on the prediction of sustained virological response (SVR) in treatme
Externí odkaz:
https://doaj.org/article/537e87fa9ade47beb71a4ea8a2010fa2
Autor:
Yoshio Aizawa
Publikováno v:
Japanese Journal of Human Geography. 70:313-326
Autor:
Kenichi Narita, Kunihiko Fukuda, Takeshi Fukuda, Yoshihiro Sakimoto, Yoshio Aizawa, Mitsuko Ariizumi
Publikováno v:
Radiology Case Reports, Vol 12, Iss 4, Pp 701-705 (2017)
Radiology Case Reports
Radiology Case Reports
Most gallbladder carcinomas are adenocarcinomas, of which mucinous carcinoma (MC) is a rare pathologic subtype. Signet ring cells are seldom found in MCs. We report an extremely rare case of gallbladder MC with signet ring cells. This is the first ra
Autor:
Yoshio Aizawa, Shinsuke Takenaga
Publikováno v:
Interventional Radiology. 2:51-58
Autor:
Yoshio Aizawa, Atsushi Hokari
Publikováno v:
Clinical and Experimental Gastroenterology
Autoimmune hepatitis (AIH) is a chronic progressive liver disease characterized by high levels of aminotransferases and autoantibodies, hypergammaglobulinemia, and interface hepatitis. AIH affects all races and all ages worldwide, regardless of sex,
Autor:
Yoshio, Aizawa
Publikováno v:
Rinsho byori. The Japanese journal of clinical pathology. 64(7)
Non-alcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases. The con- cept of NAFLD ranges from simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) and cirrhosis. The majority of NAFLD has been recognized as
Autor:
Yoshio Aizawa, Hiroshi Abe, Akihito Tsubota, Noritomo Shimada, Masanori Atsukawa, Norio Itokawa, Tomomi Okubo, Taeang Arai, Ai Nakagawa, Chisa Kondo, Katsuhiko Iwakiri, Kai Yoshizawa
Publikováno v:
Hepatology Research. 47:641-649
AIM Although interferon-free therapy with direct-acting antivirals has developed as a standard of care for chronic hepatitis C, the existence of resistance-associated variants (RAVs) has a negative impact on treatment results. Recently, several studi